T 0294/96 (Continous release pharmaceutical compositions/SYNGENTA LTD.) of 28.02.2001
- European Case Law Identifier
- ECLI:EP:BA:2001:T029496.20010228
- Date of decision
- 28 February 2001
- Case number
- T 0294/96
- Petition for review of
- -
- Application number
- 82300416.3
- IPC class
- A61K 37/02
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Continuous release pharmaceutical compositions
- Applicant name
- Syngenta Ltd.
- Opponent name
- Takeda Chemical Industries, Ltd.
Debiopharm S.A.
Schering Corporation
Société de Conseils de Recherche et d'Applications Scient.(S.C.R.A.S.)
Akzo Pharma B.V.
Boehringer Ingelheim GmbH
Ares-Serono N.V.
Abbott Laboratories
E.I. Du Pond de Nemours and Company - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56 1973European Patent Convention Art 83 1973Rules of procedure of the Boards of Appeal Art 11(2)
- Keywords
- Added subject-matter (no)
Extension of the scope of protection (no)
Sufficiency of disclosure (yes)
Inventive step - last main request (yes) - Catchword
- -
- Cited cases
- T 0004/80
- Citing cases
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the first instance with the order to maintain the patent on the basis of claim 1 submitted as last main request at oral proceedings on 27. and 28 February 2001 and a description yet to be adapted.